5-(Carboxymethylamino)-5-oxo-4-(phenylmethoxycarbonylamino)pentanoic acid | 1634-89-5

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 5-(Carboxymethylamino)-5-oxo-4-(phenylmethoxycarbonylamino)pentanoic acid
• CAS: 1634-89-5
• 化学式: C₁₅H₁₈N₂O₇
• 分子量: 338.31
• InChiKey: FDTUHSFTKCRNSD-UHFFFAOYSA-N

物化性质

• 熔点：
  152-153 °C(Solv: ethyl acetate (141-78-6); ethanol (64-17-5); ligroine (8032-32-4))
• 沸点：
  715.2±60.0 °C(Predicted)
• 密度：
  1.377±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.3
• 重原子数：
  24
• 可旋转键数：
  10
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  142
• 氢给体数：
  4
• 氢受体数：
  7

安全信息

• 海关编码：
  2924299090

文献信息

• METHOD FOR MANUFACTURING STARCH-CONTAINING FOOD
  申请人：AJINOMOTO CO., INC.

  公开号：EP3909437A1

  公开（公告）日：2021-11-17

  The present invention aims to provide a method for modifying a starch-containing food. The present invention relates to a method for producing a starch-containing food, including adding (A) an amylomaltase derived from a bacterium of the genus Thermus to the starch-containing material, and further adding (B) a protein or lipid modification enzyme, or (C) a starch degradation product or (D) a starch degradation enzyme to the starch-containing material.

  本发明旨在提供一种改良含淀粉食品的方法。 本发明涉及一种生产含淀粉食品的方法，包括向含淀粉材料中添加(A)来源于热菌属细菌的淀粉麦芽糖酶，并进一步添加(B)蛋白质或脂质改性酶，或(C)淀粉降解产物或(D)淀粉降解酶。
• Novel antibacterial agents
  申请人：Christensen G. Burton

  公开号：US20070196859A1

  公开（公告）日：2007-08-23

  This invention relates to novel multibinding compounds (agents) that are antibacterial agents. The multibinding compounds of the invention comprise from 2-10 ligands covalently connected by a linker or linkers, wherein each of said ligands in their monovalent (i.e., unlinked ) state have the ability to bind to a an enzyme involved in cell wall biosynthesis and metabolism, a precursor used in the synthesis of the bacterial cell wall and/or the bacterial cell surface thereby interfere with the synthesis and/or metabolism of the cell wall. In particular the multibinding compounds of the invention comprise from 2-10 ligands covalently connected by a linker or linkers, wherein each of said ligands has a ligand domain capable of binding to penicillin binding proteins, a transpeptidase enzyme, a substrate of a transpeptidase enzyme, a beta-lactamase enzyme, penicillinase enzyme, cephalosporinase enzyme, a transglycosylase enzyme, or a transglycosylase enzyme substrate; Preferably, the ligands are selected from the beta lactam or glycopeptide class of antibacterial agents.